Alto Neuroscience, Inc.
NYSE:ANRO · New York Stock Exchange
+$0.40 today
Vol 0.19M · Avg 0.34M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+851.46%
Period High
$27.72
Period Low
$2.20
Latest
$22.74
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Alpha Tau Medical Ltd.
NASDAQ:DRTS
$868.65M
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ:CTNM
$441.91M
DBV Technologies S.A.
NASDAQ:DBVT
$381.67M
Amarin Corporation plc
NASDAQ:AMRN
$335.06M
Silence Therapeutics plc
NASDAQ:SLN
$324.02M
Cellectis S.A.
NASDAQ:CLLS
$316.31M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$299.95M
AC Immune S.A.
NASDAQ:ACIU
$239.68M
Korro Bio, Inc.
NASDAQ:KRRO
$126.12M
Aldeyra Therapeutics, Inc.
NASDAQ:ALDX
$116.72M
What is the latest ANRO filing?
The latest filing shown is 3 dated May 29, 2026.
How many recent filings does ANRO have?
Intrinsic Alpha currently shows 20 recent filings for ANRO.
Explore More
Continue the stock analysis
Jump to another research area for this company.